Compugen (CGEN) Other financing activities (2009 - 2010)
Compugen (CGEN) posted quarterly Other financing activities of $951000.0 for Q4 2010, up 980.68% year-over-year from $88000.0 in Q4 2009, and up 1018.82% on a QoQ basis from $85000.0 in Q3 2010.
Powered by 
Analysis
Compugen (CGEN) Other financing activities (2009 - 2010) Analysis & Trends
Compugen has reported Other financing activities for 2 years, with the latest figure at $951000.0 in Q4 2010.
- Other financing activities for Q4 2010 came in at $951000.0, up 980.68% year-over-year; the trailing twelve-month figure through Dec 2010 was $1.2 million (changed N/A YoY), and the FY2025 annual result was $73000.0, up 630.0% from the prior year.
- Other financing activities climbed to $951000.0 in Q4 2010, from $85000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $951000.0 in Q4 2010 and troughed at $85000.0 in Q3 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Compugen | 242.44 Mn | 156.82 Mn | -92,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2010 | 951,000.00 |
| Sep 30, 2010 | 85,000.00 |
| Dec 31, 2009 | 88,000.00 |
| Sep 30, 2009 | 96,000.00 |